My reviews
Selected research
-
Reversible therapeutic resistance in EGFR mutant lung cancer caused by RB1 loss induced lineage plasticity.
bioRxiv : the preprint server for biology
-
Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
-
Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
4.9